# Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA

> **NCT06424639** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 58 (estimated)

## Conditions studied

- Aplastic Anemia

## Interventions

- **DRUG:** Luspatercept
- **DRUG:** cyclosporine

## Key facts

- **NCT ID:** NCT06424639
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05
- **Primary completion:** 2025-05
- **Final completion:** 2025-12
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2024-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06424639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06424639, "Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06424639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*